CUSIP 52490G102SPONSORED ADSLEGNQ4 2025
26 filings · latest Feb 5, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 24.27M | $527.59M |
| 2 | Suvretta Capital Management, LLC | 6.61M | $143.67M |
| 3 | Westfield Capital Management Co LP | 6.16M | $134.02M |
| 4 | Hhlr Advisors, Ltd. | 5.98M | $130.10M |
| 5 | Deerfield Management Company, L.P. | 5.93M | $128.96M |
| 6 | Blackrock, Inc. | 4.28M | $92.98M |
| 7 | Point72 Asset Management, L.P. | 2.78M | $60.54M |
| 8 | Artisan Partners Limited Partnership | 2.34M | $50.89M |
| 9 |
| 4 | Jun 6, 2025 | Fmr LLC | 13G/A | 10.9% | 40.16M | SEC |
| 5 | Feb 14, 2025 | T. Rowe Price Associates, Inc. | 13G/A | 3.7% | 6.81M | SEC |
| 6 | Feb 12, 2025 | Fmr LLC | 13G/A | 7.3% | 26.61M | SEC |
| 7 | Nov 14, 2024 | Price T Rowe Associates Inc /Md/ | 13G/A | 6.1% | 11.14M | SEC |
| 8 | Nov 12, 2024 | Fmr LLC | 13G/A | 10.0% | — | SEC |
| 9 | Apr 5, 2024 | Blackrock Inc. | 13G/A | 3.0% | 10.77M | SEC |
| 10 | Feb 14, 2024 | Genscript Biotech Corp | 13G/A | 48.0% | 174.50M | SEC |
See the full Schedule 13D/13G history for Legend Biotech Corp.
Unlock full history| Goldman Sachs Group Inc |
| 2.17M |
| $47.27M |
| 10 | Alliancebernstein L.P. | 1.52M | $32.98M |